ID=H0733
URL=http://hiv-web.lanl.gov/content/hiv-db/REVIEWS/BRODER99/coreceptor.html
SIZE=48552
DATE=11/07/2002
TIME=17:07:31
DATASET=Biology
HTML=  
<html>
  <head>
    <title></title>
      <style type="text/css">
	<!--
	  span.red {color: red}
	  span.green {color: green}
          span.small {size:"-1"}
	  input.lavender {background: lavender;
			  color: green}
	  ul.tip {list-style-type: none} 
	  .a11 {color: black; 
                font-size: 11pt; 
                font-weight: normal; 
                text-decoration: none; 
                font-family: Arial, Helvetica, sans-serif}
          a:link {color: blue; 
                  text-decoration : none; 
                  font-weight: normal}
	  a:visited {color : blue;
                     text-decoration : none;
                     font-weight : normal}
          a:hover {color: brown; 
                   text-decoration : none; 
                   font-weight: normal}
#pup {position:absolute; visibility:hidden; z-index:200; width:130; }
//-->
      </style>	
  </head>
  <body bgcolor="white">
    <table bgcolor="white" width="100%" border=0 cellspacing=0 cellpadding=3>
      <tr valign="top">
	<td width="10%" bgcolor="#eaeaea">
               <!--
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">

<HTML>

<HEAD>
  <TITLE>
    HIV sequence database navigation frame
  </TITLE>
</HEAD>


<BODY> 
	BACKGROUND="" 
	BGCOLOR="#eaeaea" 
	TEXT="#000000" 
	LINK="#0000ff" 
	VLINK="#800080" 
	ALINK="#ff0000"
-->

<A HREF="/content/hiv-db/mainpage.html">
	
<IMG SRC="/content/hiv-db/IMAGES/VirusTransparent.gif" BORDER=0></A>

<P>
<CENTER>
</CENTER>

<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/headerDatabases.gif" BORDER=0></A><BR>

<A HREF="/content/hiv-db/mainpage.html" 
	onMouseOver="document.Sequence.src='/content/hiv-db/NAVIFRAME/YELLOW/_SequenceDB.gif' "
	onMouseOut="document.Sequence.src='/content/hiv-db/NAVIFRAME/YELLOW/SequenceDB.gif' " >
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/SequenceDB.gif" BORDER=0 NAME="Sequence"></A><BR>

<A HREF="http://resdb.lanl.gov/Resist_DB/default.htm" 
	onMouseOver="document.Resistance.src='/content/hiv-db/NAVIFRAME/YELLOW/_ResistanceDB.gif' "
	onMouseOut="document.Resistance.src='/content/hiv-db/NAVIFRAME/YELLOW/ResistanceDB.gif'">
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/ResistanceDB.gif" BORDER=0 NAME="Resistance"></A><BR>

<A HREF="/content/immunology/index" 
	onMouseOver="document.Immunology.src='/content/hiv-db/NAVIFRAME/YELLOW/_ImmunologyDB.gif' "
	onMouseOut="document.Immunology.src='/content/hiv-db/NAVIFRAME/YELLOW/ImmunologyDB.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/ImmunologyDB.gif" BORDER=0 NAME="Immunology"></A><BR>

<A HREF="/content/vaccine/html/index.html" 
	onMouseOver="document.VaccineTrials.src='/content/hiv-db/NAVIFRAME/YELLOW/_VaccinetrialsDB.gif' "
	onMouseOut="document.VaccineTrials.src='/content/hiv-db/NAVIFRAME/YELLOW/VaccinetrialsDB.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/VaccinetrialsDB.gif" BORDER=0 NAME="VaccineTrials"></A><BR>

<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/bottom.gif" BORDER=0></A><BR>

<P>

<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/headerPublications.gif" BORDER=0></A><BR>

<A HREF="/content/hiv-db/HTML/FAQ.html" 
	onMouseOver="document.Faq.src='/content/hiv-db/NAVIFRAME/YELLOW/_FAQ.gif' "
	onMouseOut="document.Faq.src='/content/hiv-db/NAVIFRAME/YELLOW/FAQ.gif' ">
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/FAQ.gif" BORDER=0 NAME="Faq"></A><BR>

<A HREF="/content/hiv-db/ALIGN_CURRENT/ALIGN-INDEX.html" 
	onMouseOver="document.Alignments.src='/content/hiv-db/NAVIFRAME/YELLOW/_Alignments.gif' "
	onMouseOut="document.Alignments.src='/content/hiv-db/NAVIFRAME/YELLOW/Alignments.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Alignments.gif" BORDER=0 NAME="Alignments"></A><BR>

<A HREF="/content/hiv-db/HTML/Tutorials.html" 
	onMouseOver="document.Tutorials.src='/content/hiv-db/NAVIFRAME/YELLOW/_Tutorials.gif' "
	onMouseOut="document.Tutorials.src='/content/hiv-db/NAVIFRAME/YELLOW/Tutorials.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Tutorials.gif" BORDER=0 NAME="Tutorials"></A><BR>

<A HREF="/content/hiv-db/REVIEWS/reviews.html" 
	onMouseOver="document.Reviews.src='/content/hiv-db/NAVIFRAME/YELLOW/_Reviews.gif' "
	onMouseOut="document.Reviews.src='/content/hiv-db/NAVIFRAME/YELLOW/Reviews.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Reviews.gif" BORDER=0 NAME="Reviews"></A><BR>

<A HREF="/content/hiv-db/HTML/compendium.html" 
	onMouseOver="document.Compendia.src='/content/hiv-db/NAVIFRAME/YELLOW/_Compendia.gif' "
	onMouseOut="document.Compendia.src='/content/hiv-db/NAVIFRAME/YELLOW/Compendia.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Compendia.gif" BORDER=0 NAME="Compendia"></A><BR>

<A HREF="/content/hiv-db/HTML/links.html" 
	onMouseOver="document.Links.src='/content/hiv-db/NAVIFRAME/YELLOW/_Links.gif' "
	onMouseOut="document.Links.src='/content/hiv-db/NAVIFRAME/YELLOW/Links.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Links.gif" BORDER=0 NAME="Links"></A><BR>

<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/bottom.gif" BORDER=0></A><BR>

<P>

<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/headerSequenceDB.gif" BORDER=0></A><BR>

<!--
<A HREF="/content/hiv-db/MAP/hivmap.html" 
-->
<A HREF="/content/hiv-db/combined_search/search" 
	onMouseOver="document.Hivmap.src='/content/hiv-db/NAVIFRAME/YELLOW/_Search&Align.gif'"
	onMouseOut="document.Hivmap.src='/content/hiv-db/NAVIFRAME/YELLOW/Search&Align.gif'">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Search&Align.gif" BORDER=0 NAME="Hivmap"></A><BR>

<!--
<A HREF="/cgi-bin/hivDB3/public/wdb/ssampublic" 
-->
<A HREF="/content/hiv-db/combined_search/search" 
	onMouseOver="document.Searchdb.src='/content/hiv-db/NAVIFRAME/YELLOW/_SearchDB.gif' "
	onMouseOut="document.Searchdb.src='/content/hiv-db/NAVIFRAME/YELLOW/SearchDB.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/SearchDB.gif" BORDER=0 NAME="Searchdb"></A><BR>

<A HREF="/content/hiv-db/HTML/tools.html" 
	onMouseOver="document.Tools.src='/content/hiv-db/NAVIFRAME/YELLOW/_Tools.gif'"
	onMouseOut="document.Tools.src='/content/hiv-db/NAVIFRAME/YELLOW/Tools.gif'">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Tools.gif" BORDER=0 NAME="Tools"></A><BR>

<A HREF="/content/hiv-db/BASIC_BLAST/basic_blast.html" 
	onMouseOver="document.Hivblast.src='/content/hiv-db/NAVIFRAME/YELLOW/_HIV-BLAST.gif' "
	onMouseOut="document.Hivblast.src='/content/hiv-db/NAVIFRAME/YELLOW/HIV-BLAST.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/HIV-BLAST.gif" BORDER=0 NAME="Hivblast"></A><BR>

<A HREF="http://linker.lanl.gov/RIP/RIPsubmit.html" 
	onMouseOver="document.Rip.src='/content/hiv-db/NAVIFRAME/YELLOW/_Recombination.gif' "
	onMouseOut="document.Rip.src='/content/hiv-db/NAVIFRAME/YELLOW/Recombination.gif' " >
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Recombination.gif" BORDER=0 NAME="Rip"></A><BR>

<A HREF="/content/hiv-db/SNAP/WEBSNAP/SNAP.html" 
	onMouseOver="document.Snap.src='/content/hiv-db/NAVIFRAME/YELLOW/_Syn-Nonsyn.gif' "
	onMouseOut="document.Snap.src='/content/hiv-db/NAVIFRAME/YELLOW/Syn-Nonsyn.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Syn-Nonsyn.gif" BORDER=0 NAME="Snap"></A><BR>

<A HREF="/content/hiv-db/HYPERMUT/hypermut.html" 
	onMouseOver="document.Hypermut.src='/content/hiv-db/NAVIFRAME/YELLOW/_Hypermut.gif' "
	onMouseOut="document.Hypermut.src='/content/hiv-db/NAVIFRAME/YELLOW/Hypermut.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Hypermut.gif" BORDER=0 NAME="Hypermut"></A><BR>

<A HREF="/content/hiv-db/PCOORD/PCOORD.html" 
	onMouseOver="document.Pcoord.src='/content/hiv-db/NAVIFRAME/YELLOW/_PCOORD.gif' "
	onMouseOut="document.Pcoord.src='/content/hiv-db/NAVIFRAME/YELLOW/PCOORD.gif' " >
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/PCOORD.gif" BORDER=0 NAME="Pcoord"></A><BR>
    
<A HREF="/content/hiv-db/SUDI/sudi.html" 
	onMouseOver="document.SUDI.src='/content/hiv-db/NAVIFRAME/YELLOW/_SUDI.gif' "
	onMouseOut="document.SUDI.src='/content/hiv-db/NAVIFRAME/YELLOW/SUDI.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/SUDI.gif" BORDER=0 NAME="SUDI"></A><BR>

<A HREF="/content/hiv-db/CONTAM/TreeMaker/TreeMaker.html" 
	onMouseOver="document.Treemaker.src='/content/hiv-db/NAVIFRAME/YELLOW/_TreeMaker.gif' "
	onMouseOut="document.Treemaker.src='/content/hiv-db/NAVIFRAME/YELLOW/TreeMaker.gif' " >
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/TreeMaker.gif" BORDER=0 NAME="Treemaker"></A><BR>

<A HREF="/content/hiv-db/geography/map_right.html" 
	onMouseOver="document.Geography.src='/content/hiv-db/NAVIFRAME/YELLOW/_Geography.gif' "
	onMouseOut="document.Geography.src='/content/hiv-db/NAVIFRAME/YELLOW/Geography.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Geography.gif" BORDER=0 NAME="Geography"></A><BR>

<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/bottom.gif" BORDER=0></A><BR>

<!--
<br>
<small>
<small>
&nbsp;<a href="/content/hiv-db/combined_search/search">Combined Search</a>
</small>
</small>
</CENTER>
-->
<BR>
<BR>

<center>
<small>
<small>
<A HREF="http://www.lanl.gov/misc/disclaimer.html" >Disclaimer/Privacy</A>
</small>
</small>
<FONT FACE="Arial, Helvetica, sans-serif" SIZE="-2">
</FONT>
</center>

<!--
</BODY>
</HTML>
-->


        </td>
	<td>
	  <table border="0" cellspacing="0" cellpadding="3">
	    <tr><td>
            </td></tr>
	    <tr><td><HTML>
<!--This file created 7/14/00 3:57 PM by Claris Home Page version 3.0-->
<HEAD>
   <TITLE>coreceptor</TITLE>
   <META NAME=GENERATOR CONTENT="Claris Home Page 3.0">
   <X-CLARIS-WINDOW TOP=42 BOTTOM=621 LEFT=4 RIGHT=534>
   <X-CLARIS-TAGVIEW MODE=minimal>
</HEAD>
<BODY BGCOLOR="#FFFFFF">
<H2>Coreceptor Use by Primate Lentiviruses</H2>

<P>&nbsp;</P>

<P><B>Christopher C. Broder and Agnes Jones-Trower</B></P>

<P>Department of Microbiology and Immunology, F. Edward H&eacute;bert
School of Medicine</P>

<P>Uniformed Services University of the Health Sciences,</P>

<P>4301 Jones Bridge Road, Bethesda, MD 20814-4799</P>

<P>Phone: 301-295-3401, Fax: 301-295-1545, email: <A HREF="mailto:cbroder@mxb.usuhs.mil">cbroder@mxb.usuhs.mil</A></P>

<P>&nbsp;</P>

<P>The original compilation of the data in the accompanying tables in
this section on coreceptor use by HIV-1, HIV-2, and SIV was performed
over the past two years by Robert W. Doms and Aimee L. Edinger of the
University of Pennsylvania, Department of Pathology and Laboratory
Medicine and John P. Moore of The Aaron Diamond AIDS Research Center,
The Rockefeller University. This year we have updated and revised the
information in these tables for the purpose of maintaining this
database on the salient points of virus isolate characteristics and
usage of these seven transmembrane domain (7TM) coreceptors. In
addition, we have included all HIV-1 isolates and their relevant
information from the NIH AIDS Research and Reference Reagent Program
that were not already in the existing HIV-1 isolate table. The
coreceptor usage data included in this review is included as a
searchable field for HIV sequence retrieval at the HIV database web
site, http://hiv-web.lanl.gov. Corrections to errors or additional
information that would improve these tables are welcome and should be
sent by electronic mail to: cbroder@mxb.usuhs.mil.</P>

<P><TABLE BORDER=0 WIDTH="100%">
   <TR>
      <TD>
         <P><A HREF="HIV1table.html">HIV-1 Table</A></P>
      </TD>
      <TD>
         <P><A HREF="NIHtable.html">NIH Reagent Table</A></P>
      </TD>
      <TD>
         <P><A HREF="HIV2table.html">HIV-2 Table</A></P>
      </TD>
      <TD>
         <P><A HREF="SIVtable.html">SIV Table</A></P>
      </TD>
   </TR>
</TABLE>
</P>

<H3>Summary</H3>

<P>Parallel tracks of HIV research began almost simultaneously in two
very different arenas, namely immunology and virology. One field
focused on the structural and functional characterization of how
HIV-1 entered a host cell, with the goal of teasing out the steps and
requirements for infection, whereas the other line of research
endeavored to define host factors capable of inhibiting HIV-1
replication. For over a decade these lines of research continued but
remained essentially separated. Their findings individually built-up
our understanding of the biology of HIV until crossovers occurred,
shedding light on at least two long-standing unknowns about the
virus: (i) some soluble suppressive factors are chemokines and (ii)
the tropism-determining/influencing coreceptors for virus entry are
chemokine receptors.</P>

<P>A significant part of the overall modulation of HIV-1 replication
and the progress of HIV-1-induced disease occurs via a balance of
host factors Fauci96,Levy98. Some of these factors, such as
pro-inflammatory cytokines and cellular activation, stimulate viral
replication while other inhibitory factors may counteract disease
progression. The ligands for the chemokine receptors being utilized
as coreceptors for HIV-1 entry and infection are the newly discovered
suppressive factors. Further, it has long been noted that there is a
temporal change in viral tropism during the course of HIV-1 infection
as related to the switch from NSI to SI phenotype and, for the most
part, can now be correlated to the specific use of different
coreceptors. This switch could be related to colonization of
different types of cells rather than escape from immune system
pressure. It has been proposed that the antigenic diversity of the
HIV-1 envelope glycoprotein could be primarily driven by adaptation
to new coreceptors and only secondarily by immune selection Weiss96
based on these observations: the properties of the HIV-1 coreceptors;
the diversity of retrovirus receptors; and the availability of
numerous seven transmembrane domain receptors on cell surfaces. It
has also been suggested that during the long infection period, the
HIV-1 quasispecies has the opportunity to colonize new cell types,
thus gradually invading different subsets of hematopoietic and brain
cells Weiss96. Of further interest, it has also been observed that
feline immunodeficiency virus (FIV) can use CXCR4 to infect and fuse
in a CD4-independent manner Willett97. It appears that chemokine
receptors could be a common link between FIV and the primate
lentiviruses Willett97. It is tempting to speculate that chemokine
receptors (or other multiple membrane spanning receptors) were
originally used as primary (and possibly exclusive) receptors by
lentiviruses, and that the adaptation to use CD4 was a later event (a
notion first proposed by R. Weiss).</P>

<P>Other retroviruses do utilize various multiple membrane-spanning
domain proteins (reviewed in Weiss93,Weiss95). It was previously
proposed that perhaps HIV-1 has developed a dependence on CD4 and
CXCR4 or CCR5 because the CD4 and the 7TM receptor(s) are
co-localized in the cell membrane Broder96. It may be that CD4 and
certain 7TM receptors have some functional interacting role in the
cells of the immune system. Indeed, a constitutive association
between the CD4 and CCR5 receptors has recently been demonstrated,
Xiao99 and this observation may also explain why macrophages
expressing CXCR4 and CCR5 are predominately only a target for
M-tropic isolates of HIV-1 Dimitrov99. In fact, the involvement of a
7TM protein in HIV-1 infection was postulated in 1995 by W. Gallaher,
Gallaher95 in the context of a 'multiple receptor' requirement. Based
on the utilization by ecotropic murine leukemia virus of a multiple
membrane spanning receptor (but in fact a 14 TM rather than 7TM
glycoprotein) Albritton89 they proposed a structural model in which
multiple domains of the gp120 subunit of the envelope glycoprotein
would interact with a 7TM host cell molecule in addition to CD4.</P>

<P>Continued progress over the past year has been made detailing
coreceptor usage for HIV-1, HIV-2, and SIV strains, and in describing
new virus isolates along with their salient features. It was
previously proposed that perhaps HIV-1 has developed a dependence on
CD4 and CCR5 or CXCR4 because the CD4 and the 7TM receptor(s) are
co-localized in the cell membrane Broder96. Indeed, it may be that
CD4 and certain 7TM receptors have some, yet to be discovered,
functional interacting role in the cells of the immune system. In
fact, a constitutive biochemical association between the CD4 and CCR5
receptors which supports such a model has recently been demonstrated
Xiao99. On the other hand, the endogenous association between CD4 and
the CXCR4 coreceptor appears much weaker and is more easily measured
only after complexed with HIV-1 gp120 Lapham96,Dimitrov99. The
observation that the CCR5-CD4 interaction is stronger than the
CXCR4-CD4 interaction may also explain why macrophages expressing
both these coreceptors are predominately only a target for M-tropic
isolates of HIV-1 Dimitrov99. In addition, the important observations
of coreceptor use by several virus isolates in the absence of CD4
have suggested new hypotheses concerning the evolution of HIV-1,
HIV-2 and SIV, the mechanism of the receptor-induced membrane fusion
process, and the structure of the coreceptor molecules. The number of
coreceptors used by HIV and SIV is now 14 (CCR5, CXCR4, CCR3, CCR2b,
STRL33 (Bonzo), GPR1, GPR15 (BOB), CCR8, CCR9, CCR1, CCR4, CX3CR1
(formerly V28), APJ and US28). This number does not include non-human
analogues (other than US28) and is likely to grow. However, it is now
well recognized that the principal HIV-1 coreceptors remain the
initially discovered CXC chemokine receptor CXCR4 and the
CC-chemokine receptor CCR5, and all HIV-1, HIV-2, and SIV strains
reported on to date use one or both of these receptors. Unlike HIV-1,
it appears that many isolates of HIV-2 and SIV have the added ability
to employ alternate coreceptors with efficiencies comparable to that
with either CXCR4 or CCR5 depending on the particular isolate, and
some can employ the coreceptor in the absence of CD4. It remains an
open question as to whether use of alternative coreceptors in vivo is
an important feature in viral tropism, pathogenesis or other facets
of the natural history of these viruses. Indeed, the use of alternate
coreceptors other than CCR5 or CXCR4, or their use in a
CD4-independent manner, could enable particular virus strains to
engage new cellular targets in vivo. There have been numerous reviews
published on the subject of HIV/SIV and the coreceptors since 1996
which serve as the best source of detailed information and citations
for readers of these tables. Broder96, Moore97a, Broder97,
Dimitrov97, Doranz97, Dimitrov98, Berson98, Gabuzda98, Rucker98,
Berger99, Clapham99, Edinger99b, Hoffman99, Michael99, Kalinkovich99,
Ross99, Lee99 These new data concerning the cellular coreceptors for
HIV and the natural chemokine ligands for those receptors continues
to advance our understanding of HIV pathogenesis and has offered new
therapeutic and preventive strategies.</P>

<P>The coreceptor use tables are updated from last year. The major
coreceptor(s) used by each virus strain is listed, as are alternative
coreceptors that support virus infection in vitro to an extent that
is ~10% of the efficiency of the major coreceptor used by each virus
strain.</P>

<P>&#91;Albert87&#93; J. Albert, U. Bredberg, F. Chiodi, B. Bottiger,
E. M. Fenyo, E. Norrby, G. Biberfeld, A new human retrovirus isolate
of West African origin (SBL-6669) and its relationship to HTLV-IV,
LAV-II, and HTLV-IIIB, <I>AIDS Res Hum Retroviruses</I>,<B>3</B>:3-10
(1987).</P>

<P>&#91;Alkhatib96&#93; G. Alkhatib, C. Combadiere, C. C. Broder, Y.
Feng, P. E. Kennedy, P. M. Murphy, E. A. Berger, CC CKR5: a RANTES,
MIP-1alpha, MIP-1beta receptor as a fusion cofactor for
macrophage-tropic HIV-1, <I>Science</I>,<B>272</B>:1955-8 (1996).</P>

<P>&#91;Amedee95&#93; A. M. Amedee, N. Lacour, J. L. Gierman, L. N.
Martin, J. E. Clements, R. Bohm, R. M. Harrison, M. Murphey-Corb,
Genotypic selection of simian immunodeficiency virus in macaque
infants infected transplacentally, <I>J Virol</I>,<B>69</B>:7982-90
(1995).</P>

<P>&#91;Balotta97&#93; C. Balotta, P. Bagnarelli, M. Violin, A. L.
Ridolfo, D. Zhou, A. Berlusconi, S. Corvasce, M. Corbellino, M.
Clementi, M. Clerici, M. Moroni, M. Galli, Homozygous delta 32
deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected
patient, <I>AIDS</I>,<B>11</B>:F67-71 (1997).</P>

<P>&#91;Banapour91a&#93; B. Banapour, M. L. Marthas, R. J. Munn, P.
A. Luciw, In vitro macrophage tropism of pathogenic and nonpathogenic
molecular clones of simian immunodeficiency virus (SIVmac),
<I>Virology</I>,<B>183</B>:12-9 (1991).</P>

<P>&#91;Banapour91b&#93; B. Banapour, M. L. Marthas, R. A. Ramos, B.
L. Lohman, R. E. Unger, M. B. Gardner, N. C. Pedersen, P. A. Luciw,
Identification of viral determinants of macrophage tropism for simian
immunodeficiency virus SIVmac, <I>J Virol</I>,<B>65</B>:5798-805
(1991).</P>

<P>&#91;Barnett96&#93; S. W. Barnett, H. S. Legg, Y. Sun, J. Klinger,
D. J. Blackbourn, C. P. Locher, J. A. Levy, Molecular cloning of the
human immunodeficiency virus subtype 2 strain HIV-2UC2,
<I>Virology</I>,<B>222</B>:257-61 (1996).</P>

<P>&#91;Bazan98&#93; H. A. Bazan, G. Alkhatib, C. C. Broder, E. A.
Berger, Patterns of CCR5, CXCR4, and CCR3 usage by envelope
glycoproteins from human immunodeficiency virus type 1 primary
isolates, <I>J Virol</I>,<B>72</B>:4485-91 (1998).</P>

<P>&#91;Berger97a&#93; E. A. Berger, HIV1 entry and tropism: the
chemokine receptor connection, <I>AIDS</I>,<B>11 (supplement
A)</B>:S3-S16 (1997).</P>

<P>&#91;Berger97b&#93; E. A. Berger, R. W. Doms, E.-M. Fenyo, B. T.
M. Korber, D. R. Littman, J. P. Moore, Q. J. Sattentau, H.
Schuitmaker, J. Sodroski, R. A. Weiss, HIV-1 phenotypes classified by
coreceptor usage, <I>Nature</I>,<B>In press</B>: (1997).</P>

<P>&#91;Biti97&#93; R. Biti, R. Ffrench, J. Young, B. Bennetts, G.
Stewart, T. Liang, HIV-1 infection in an individual homozygous for
the CCR5 deletion allele (letter; comment), <I>Nat
Med</I>,<B>3</B>:252-3 (1997).</P>

<P>&#91;Bjorndal97&#93; A. Bjorndal, H. Deng, M. Jansson, J. R.
Fiore, C. Colognesi, A. Karlsson, J. Albert, G. Scarlatti, D. R.
Littman, E. M. Fenyo, Coreceptor usage of primary human
immunodeficiency virus type 1 isolates varies according to biological
phenotype, <I>J Virol</I>,<B>71</B>:7478-87 (1997).</P>

<P>&#91;Brelot97&#93; A. Brelot, N. Heveker, O. Pleskoff, N. Sol, M.
Alizon, Role of the first and third extracellular domains of CXCR-4
in human immunodeficiency virus coreceptor activity, <I>J
Virol</I>,<B>71</B>:4744-51 (1997).</P>

<P>&#91;Broder97&#93; C. C. Broder, R. G. Collman, Chemokine
receptors and HIV, <I>J Leukoc Biol</I>,<B>62</B>:20-9 (1997).</P>

<P>&#91;Bron97&#93; R. Bron, P. J. Klasse, D. Wilkinson, P. R.
Clapham, A. Pelchen-Matthews, C. Power, T. N. Wells, J. Kim, S. C.
Peiper, J. A. Hoxie, M. Marsh, Promiscuous use of CC and CXC
chemokine receptors in cell-to-cell fusion mediated by a human
immunodeficiency virus type 2 envelope protein, <I>J
Virol</I>,<B>71</B>:8405-15 (1997).</P>

<P>&#91;Chackerian97&#93; B. Chackerian, E. M. Long, P. A. Luciw, J.
Overbaugh, Human immunodeficiency virus type 1 coreceptors
participate in postentry stages in the virus replication cycle and
function in simian immunodeficiency virus infection, <I>J
Virol</I>,<B>71</B>:3932-9 (1997).</P>

<P>&#91;Chakrabarti90&#93; S. Chakrabarti, T. Mizukami, G. Franchini,
B. Moss, Synthesis, oligomerization, and biological activity of the
human immunodeficiency virus type 2 envelope glycoprotein expressed
by a recombinant vaccinia virus, <I>Virology</I>,<B>178</B>:134-42
(1990).</P>

<P>&#91;Chen97&#93; Z. Chen, P. Zhou, D. D. Ho, N. R. Landau, P. A.
Marx, Genetically divergent strains of simian immunodeficiency virus
use CCR5 as a coreceptor for entry, <I>J Virol</I>,<B>71</B>:2705-14
(1997).</P>

<P>&#91;Chen98a&#93; Z. Chen, A. Gettie, D. D. Ho, P. A. Marx,
Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys
naturally infected in west Africa: a comparison of coreceptor usage
of primary SIVsm, HIV-2, and SIVmac,
<I>Virology</I>,<B>246</B>:113-24 (1998).</P>

<P>&#91;Chen98b&#93; Z. Chen, D. Kwon, Z. Jin, S. Monard, P. Telfer,
M. S. Jones, C. Y. Lu, R. F. Aguilar, D. D. Ho, P. A. Marx, Natural
infection of a homozygous delta24 CCR5 red-capped mangabey with an
R2b-tropic simian immunodeficiency virus, <I>J Exp
Med</I>,<B>188</B>:2057-65 (1998).</P>

<P>&#91;Choe96&#93; H. Choe, M. Farzan, Y. Sun, N. Sullivan, B.
Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N.
Gerard, C. Gerard, J. Sodroski, The beta-chemokine receptors CCR3 and
CCR5 facilitate infection by primary HIV-1 isolates,
<I>Cell</I>,<B>85</B>:1135-48 (1996).</P>

<P>&#91;Choe98&#93; H. Choe, M. Farzan, M. Konkel, K. Martin, Y. Sun,
L. Marcon, M. Cayabyab, M. Berman, M. E. Dorf, N. Gerard, C. Gerard,
J. Sodroski, The orphan seven-transmembrane receptor apj supports the
entry of primary T-cell-line-tropic and dualtropic human
immunodeficiency virus type 1, <I>J Virol</I>,<B>72</B>:6113-8
(1998).</P>

<P>&#91;Clapham92&#93; P. R. Clapham, A. McKnight, R. A. Weiss, Human
immunodeficiency virus type 2 infection and fusion of CD4- negative
human cell lines: induction and enhancement by soluble CD4, <I>J
Virol</I>,<B>66</B>:3531-7 (1992).</P>

<P>&#91;Clavel86&#93; F. Clavel, D. Guetard, F. Brun-Vezinet, S.
Chamaret, M. A. Rey, M. O. Santos-Ferreira, A. G. Laurent, C.
Dauguet, C. Katlama, C. Rouzioux, Isolation of a new human retrovirus
from West African patients with AIDS, <I>Science</I>,<B>233</B>:343-6
(1986).</P>

<P>&#91;Collman92&#93; R. Collman, J. W. Balliet, S. A. Gregory, H.
Friedman, D. L. Kolson, N. Nathanson, A. Srinivasan, An infectious
molecular clone of an unusual macrophage-tropic and highly cytopathic
strain of human immunodeficiency virus type 1, <I>J
Virol</I>,<B>66</B>:7517-21 (1992).</P>

<P>&#91;Connor93&#93; R. I. Connor, H. Mohri, Y. Cao, D. D. Ho,
Increased viral burden and cytopathicity correlate temporally with
CD4+ T-lymphocyte decline and clinical progression in human
immunodeficiency virus type 1-infected individuals, <I>J
Virol</I>,<B>67</B>:1772-7 (1993).</P>

<P>&#91;Dean96&#93; M. Dean, M. Carrington, C. Winkler, G. A.
Huttley, M. W. Smith, R. Allikmets, J. J. Goedert, S. P. Buchbinder,
E. Vittinghoff, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A.
Saah, C. Rinaldo, R. Detels, S. J. O'Brien, Genetic restriction of
HIV-1 infection and progression to AIDS by a deletion allele of the
CKR5 structural gene. Hemophilia Growth and Development Study,
Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study,
San Francisco City Cohort, ALIVE Study (see comments) (published
erratum appears in Science 1996 Nov 15;274(5290):1069),
<I>Science</I>,<B>273</B>:1856-62 (1996).</P>

<P>&#91;DeJong92&#93; J. J. de Jong, J. Goudsmit, W. Keulen, B.
Klaver, W. Krone, M. Tersmette, A. de Ronde, Human immunodeficiency
virus type 1 clones chimeric for the envelope V3 domain differ in
syncytium formation and replication capacity, <I>J
Virol</I>,<B>66</B>:757-65 (1992).</P>

<P>&#91;Deng97&#93; H. K. Deng, D. Unutmaz, V. N. KewalRamani, D. R.
Littman, Expression cloning of new receptors used by simian and human
immunodeficiency viruses (see comments),
<I>Nature</I>,<B>388</B>:296-300 (1997).</P>

<P>&#91;Dittmar97&#93; M. T. Dittmar, G. Simmons, S. Hibbitts, M.
O'Hare, S. Louisirirotchanakul, S. Beddows, J. Weber, P. R. Clapham,
R. A. Weiss, Langerhans cell tropism of human immunodeficiency virus
type 1 subtype A through F isolates derived from different
transmission groups, <I>J Virol</I>,<B>71</B>:8008-13 (1997).</P>

<P>&#91;Doms97&#93; R. W. Doms, S. C. Peiper, Unwelcomed guests with
master keys: how HIV uses chemokine receptors for cellular entry,
<I>Virology</I>,<B>235</B>:179-90 (1997).</P>

<P>&#91;Doranz96&#93; B. J. Doranz, J. Rucker, Y. Yi, R. J. Smyth, M.
Samson, S. C. Peiper, M. Parmentier, R. G. Collman, R. W. Doms, A
dual-tropic primary HIV-1 isolate that uses fusin and the beta-
chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors,
<I>Cell</I>,<B>85</B>:1149-58 (1996).</P>

<P>&#91;Dragic96&#93; T. Dragic, V. Litwin, G. P. Allaway, S. R.
Martin, Y. Huang, K. A. Nagashima, C. Cayanan, P. J. Maddon, R. A.
Koup, J. P. Moore, W. A. Paxton, HIV-1 entry into CD4+ cells is
mediated by the chemokine receptor CC- CKR-5 (see comments),
<I>Nature</I>,<B>381</B>:667-73 (1996).</P>

<P>&#91;Edinger97a&#93; A. L. Edinger, A. Amedee, K. Miller, B. J.
Doranz, M. Endres, M. Sharron, M. Samson, Z. H. Lu, J. E. Clements,
M. Murphey-Corb, S. C. Peiper, M. Parmentier, C. C. Broder, R. W.
Doms, Differential utilization of CCR5 by macrophage and T cell
tropic simian immunodeficiency virus strains, <I>Proc Natl Acad Sci U
S A</I>,<B>94</B>:4005-10 (1997).</P>

<P>&#91;Edinger97b&#93; A. L. Edinger, J. L. Mankowski, B. J. Doranz,
B. J. Margulies, B. Lee, J. Rucker, M. Sharron, T. L. Hoffman, J. F.
Berson, M. C. Zink, V. M. Hirsch, J. E. Clements, R. W. Doms,
CD4-independent, CCR5-dependent infection of brain capillary
endothelial cells by a neurovirulent simian immunodeficiency virus
strain, <I>Proc Natl Acad Sci U S A</I>,<B>94</B>:14742-7 (1997).</P>

<P>&#91;Edinger98a&#93; A. L. Edinger, T. L. Hoffman, M. Sharron, B.
Lee, B. O'Dowd, R. W. Doms, Use of GPR1, GPR15, and STRL33 as
coreceptors by diverse human immunodeficiency virus type 1 and simian
immunodeficiency virus envelope proteins,
<I>Virology</I>,<B>249</B>:367-78 (1998).</P>

<P>&#91;Edinger98b&#93; A. L. Edinger, T. L. Hoffman, M. Sharron, B.
Lee, Y. Yi, W. Choe, D. L. Kolson, B. Mitrovic, Y. Zhou, D. Faulds,
R. G. Collman, J. Hesselgesser, R. Horuk, R. W. Doms, An orphan
seven-transmembrane domain receptor expressed widely in the brain
functions as a coreceptor for human immunodeficiency virus type 1 and
simian immunodeficiency virus, <I>J Virol</I>,<B>72</B>:7934-40
(1998).</P>

<P>&#91;Edingersubmit&#93; A. L. Edinger, C. Blanpain, K. Kunstman,
S. M. Wolinsky, M. Endres, M. Parmentier, R. W. Doms, Functional
dissection of CCR5 coreceptor function through the use of
CD4-independent SIV strains, ,: (1999).</P>

<P>&#91;Endres96&#93; M. J. Endres, P. R. Clapham, M. Marsh, M.
Ahuja, J. D. Turner, A. McKnight, J. F. Thomas, B.
Stoebenau-Haggarty, S. Choe, P. J. Vance, T. N. Wells, C. A. Power,
S. S. Sutterwala, R. W. Doms, N. R. Landau, J. A. Hoxie,
CD4-independent infection by HIV-2 is mediated by fusin/CXCR4,
<I>Cell</I>,<B>87</B>:745-56 (1996).</P>

<P>&#91;Evans88&#93; L. A. Evans, J. Moreau, K. Odehouri, D. Seto, G.
Thomson-Honnebier, H. Legg, A. Barboza, C. Cheng-Mayer, J. A. Levy,
Simultaneous isolation of HIV-1 and HIV-2 from an AIDS patient,
<I>Lancet</I>,<B>2</B>:1389-91 (1988).</P>

<P>&#91;Farzan97&#93; M. Farzan, H. Choe, K. Martin, L. Marcon, W.
Hofmann, G. Karlsson, Y. Sun, P. Barrett, N. March, , N. Sullivan, N.
Gerard, C. Gerard, J. Sodroski, Two orphan seven-transmembrane
segment receptors which are expressed in CD4-positive cells support
simian immunodeficiency virus infection, <I>J Exp
Med.</I>,<B>186</B>:405-11 (1997).</P>

<P>&#91;Feng96&#93; Y. Feng, C. C. Broder, P. E. Kennedy, E. A.
Berger, HIV-1 entry cofactor: functional cDNA cloning of a
seven-transmembrane, G protein-coupled receptor (see comments),
<I>Science</I>,<B>272</B>:872-7 (1996).</P>

<P>&#91;Fenyo88&#93; E. M. Fenyo, L. Morfeldt-Manson, F. Chiodi, B.
Lind, A. von Gegerfelt, J. Albert, E. Olausson, B. Asjo, Distinct
replicative and cytopathic characteristics of human immunodeficiency
virus isolates, <I>J Virol</I>,<B>62</B>:4414-9 (1988).</P>

<P>&#91;Flaherty97&#93; M. T. Flaherty, D. A. Hauer, J. L. Mankowski,
M. C. Zink, J. E. Clements, Molecular and biological characterization
of a neurovirulent molecular clone of simian immunodeficiency virus,
<I>J Virol</I>,<B>71</B>:5790-8 (1997).</P>

<P>&#91;Fouchier92&#93; R. A. Fouchier, M. Groenink, N. A. Kootstra,
M. Tersmette, H. G. Huisman, F. Miedema, H. Schuitemaker,
Phenotype-associated sequence variation in the third variable domain
of the human immunodeficiency virus type 1 gp120 molecule, <I>J
Virol</I>,<B>66</B>:3183-7 (1992).</P>

<P>&#91;Gao92&#93; F. Gao, L. Yue, A. T. White, P. G. Pappas, J.
Barchue, A. P. Hanson, B. M. Greene, P. M. Sharp, G. M. Shaw, B. H.
Hahn, Human infection by genetically diverse SIVSM-related HIV-2 in
west Africa, <I>Nature</I>,<B>358</B>:495-9 (1992).</P>

<P>&#91;Guillon98&#93; C. Guillon, M. E. van der Ende, P. H. Boers,
R. A. Gruters, M. Schutten, A. D. Osterhaus, Coreceptor usage of
human immunodeficiency virus type 2 primary isolates and biological
clones is broad and does not correlate with their syncytium-inducing
capacities, <I>J Virol</I>,<B>72</B>:6260-3 (1998).</P>

<P>&#91;He97&#93; J. He, Y. Chen, M. Farzan, H. Choe, A. Ohagen, S.
Gartner, J. Busciglio, X. Yang, W. Hofmann, W. Newman, C. R. Mackay,
J. Sodroski, D. Gabuzda, CCR3 and CCR5 are co-receptors for HIV-1
infection of microglia, <I>Nature</I>,<B>385</B>:645-9 (1997).</P>

<P>&#91;Heredia97&#93; A. Heredia, A. Vallejo, V. Soriano, J. S.
Epstein, I. K. Hewlett, Chemokine receptors and HIV-2
&#91;letter&#93;, <I>AIDS</I>,<B>11</B>:1198-9 (1997).</P>

<P>&#91;Hill97&#93; C. M. Hill, H. Deng, D. Unutmaz, V. N.
Kewalramani, L. Bastiani, M. K. Gorny, S. Zolla-Pazner, D. R.
Littman, Envelope glycoproteins from human immunodeficiency virus
types 1 and 2 and simian immunodeficiency virus can use human CCR5 as
a coreceptor for viral entry and make direct CD4-dependent
interactions with this chemokine receptor, <I>J
Virol</I>,<B>71</B>:6296-304 (1997).</P>

<P>&#91;Hill98&#93; C. M. Hill, D. Kwon, M. Jones, C. B. Davis, S.
Marmon, B. L. Daugherty, J. A. DeMartino, M. S. Springer, D. Unutmaz,
D. R. Littman, The amino terminus of human CCR5 is required for its
function as a receptor for diverse human and simian immunodeficiency
virus envelope glycoproteins, <I>Virology</I>,<B>248</B>:357-71
(1998).</P>

<P>&#91;Hirsch94&#93; V. M. Hirsch, J. E. Martin, G. Dapolito, W. R.
Elkins, W. T. London, S. Goldstein, P. R. Johnson, Spontaneous
substitutions in the vicinity of the V3 analog affect cell tropism
and pathogenicity of simian immunodeficiency virus, <I>J
Virol</I>,<B>68</B>:2649-61 (1994).</P>

<P>&#91;Hirsch95&#93; V. M. Hirsch, G. Dapolito, P. R. Johnson, W. R.
Elkins, W. T. London, R. J. Montali, S. Goldstein, C. Brown,
Induction of AIDS by simian immunodeficiency virus from an African
green monkey: species-specific variation in pathogenicity correlates
with the extent of in vivo replication, <I>J
Virol</I>,<B>69</B>:955-67 (1995).</P>

<P>&#91;Hirsch97&#93; V. Hirsch, D. Adger-Johnson, B. Campbell, S.
Goldstein, C. Brown, W. R. Elkins, D. C. Montefiori, A molecularly
cloned, pathogenic, neutralization-resistant simian immunodeficiency
virus, SIVsmE543-3, <I>J Virol</I>,<B>71</B>:1608-20 (1997).</P>

<P>&#91;Kirchhoff94&#93; F. Kirchhoff, K. Mori, R. C. Desrosiers, The
V3 domain is a determinant of simian immunodeficiency virus cell
tropism, <I>J Virol</I>,<B>68</B>:3682-92 (1994).</P>

<P>&#91;Kirchhoff97&#93; F. Kirchhoff, S. Pohlmann, M. Hamacher, R.
E. Means, T. Kraus, K. Uberla, P. Di Marzio, Simian immunodeficiency
virus variants with differential T-cell and macrophage tropism use
CCR5 and an unidentified cofactor expressed in CEMx174 cells for
efficient entry, <I>J Virol</I>,<B>71</B>:6509-16 (1997).</P>

<P>&#91;Koenig89&#93; S. Koenig, V. M. Hirsch, R. A. Olmsted, D.
Powell, W. Maury, A. Rabson, A. S. Fauci, R. H. Purcell, P. R.
Johnson, Selective infection of human CD4+ cells by simian
immunodeficiency virus: productive infection associated with envelope
glycoprotein- induced fusion, <I>Proc Natl Acad Sci U S
A</I>,<B>86</B>:2443-7 (1989).</P>

<P>&#91;Kozak97&#93; S. L. Kozak, E. J. Platt, N. Madani, F. E. Ferro
Jr, K. Peden, D. Kabat, CD4, CXCR-4, and CCR-5 dependencies for
infections by primary patient and laboratory-adapted isolates of
human immunodeficiency virus type 1, <I>J Virol</I>,<B>71</B>:873-82
(1997).</P>

<P>&#91;Kuhmann97&#93; S. E. Kuhmann, E. J. Platt, S. L. Kozak, D.
Kabat, Polymorphisms in the CCR5 genes of African green monkeys and
mice implicate specific amino acids in infections by simian and human
immunodeficiency viruses, <I>J Virol</I>,<B>71</B>:8642-56
(1997).</P>

<P>&#91;Liao97&#93; F. Liao, G. Alkhatib, K. W. Peden, G. Sharma, E.
A. Berger, J. M. Farber, STRL33, A novel chemokine receptor-like
protein, functions as a fusion cofactor for both macrophage-tropic
and T cell line-tropic HIV-1, <I>J Exp Med</I>,<B>185</B>:2015-23
(1997).</P>

<P>&#91;Liu96&#93; R. Liu, W. A. Paxton, S. Choe, D. Ceradini, S. R.
Martin, R. Horuk, M. E. MacDonald, H. Stuhlmann, R. A. Koup, N. R.
Landau, Homozygous defect in HIV-1 coreceptor accounts for resistance
of some multiply-exposed individuals to HIV-1 infection,
<I>Cell</I>,<B>86</B>:367-77 (1996).</P>

<P>&#91;Lu97&#93; Z. Lu, J. F. Berson, Y. Chen, J. D. Turner, T.
Zhang, M. Sharron, M. H. Jenks, Z. Wang, J. Kim, J. Rucker, J. A.
Hoxie, S. C. Peiper, R. W. Doms, Evolution of HIV-1 coreceptor usage
through interactions with distinct CCR5 and CXCR4 domains, <I>Proc
Natl Acad Sci U S A</I>,<B>94</B>:6426-31 (1997).</P>

<P>&#91;Luciw92&#93; P. A. Luciw, K. E. Shaw, R. E. Unger, V.
Planelles, M. W. Stout, J. E. Lackner, E. Pratt-Lowe, N. J. Leung, B.
Banapour, M. L. Marthas, Genetic and biological comparisons of
pathogenic and nonpathogenic molecular clones of simian
immunodeficiency virus (SIVmac), <I>AIDS Res Hum
Retroviruses</I>,<B>8</B>:395-402 (1992).</P>

<P>&#91;Marcon97&#93; L. Marcon, H. Choe, K. A. Martin, M. Farzan, P.
D. Ponath, L. Wu, W. Newman, N. Gerard, C. Gerard, J. Sodroski,
Utilization of C-C chemokine receptor 5 by the envelope glycoproteins
of a pathogenic simian immunodeficiency virus, SIVmac239, <I>J
Virol</I>,<B>71</B>:2522-7 (1997).</P>

<P>&#91;Marx98&#93; P. A. Marx, Z. Chen, The function of simian
chemokine receptors in the replication of SIV, <I>Semin
Immunol</I>,<B>10</B>:215-23 (1998).</P>

<P>&#91;McKnight98&#93; A. McKnight, M. T. Dittmar, J. Moniz-Periera,
K. Ariyoshi, J. D. Reeves, S. Hibbitts, D. Whitby, E. Aarons, A. E.
Proudfoot, H. Whittle, P. R. Clapham, A broad range of chemokine
receptors are used by primary isolates of human immunodeficiency
virus type 2 as coreceptors with CD4, <I>J
Virol</I>,<B>72</B>:4065-71 (1998).</P>

<P>&#91;Michael97&#93; N. L. Michael, G. Chang, L. G. Louie, J. R.
Mascola, D. Dondero, D. L. Birx, H. W. Sheppard, The role of viral
phenotype and CCR-5 gene defects in HIV-1 transmission and disease
progression, <I>Nat Med</I>,<B>3</B>:338-40 (1997).</P>

<P>&#91;Moore97&#93; J. P. Moore, Coreceptors: implications for HIV
pathogenesis and therapy, <I>Science</I>,<B>276</B>:51-2 (1997).</P>

<P>&#91;Novembre93&#93; F. J. Novembre, P. R. Johnson, M. G. Lewis,
D. C. Anderson, S. Klumpp, H. M. McClure, V. M. Hirsch, Multiple
viral determinants contribute to pathogenicity of the acutely lethal
simian immunodeficiency virus SIVsmmPBj variant, <I>J
Virol</I>,<B>67</B>:2466-74 (1993).</P>

<P>&#91;OBrien97&#93; T. R. O'Brien, C. Winkler, M. Dean, J. A.
Nelson, M. Carrington, N. L. Michael, G. C. White 2nd, HIV-1
infection in a man homozygous for CCR5 delta 32 (letter),
<I>Lancet</I>,<B>349</B>:1219 (1997).</P>

<P>&#91;Owen98&#93; S. M. Owen, D. Ellenberger, M. Rayfield, S.
Wiktor, P. Michel, M. H. Grieco, F. Gao, B. H. Hahn, R. B. Lal,
Genetically divergent strains of human immunodeficiency virus type 2
use multiple coreceptors for viral entry, <I>J
Virol</I>,<B>72</B>:5425-32 (1998).</P>

<P>&#91;Pleskoff97a&#93; O. Pleskoff, C. Treboute, A. Brelot, N.
Heveker, M. Seman, M. Alizon, Identification of a chemokine receptor
encoded by human cytomegalovirus as a cofactor for HIV-1 entry (see
comments), <I>Science</I>,<B>276</B>:1874-8 (1997).</P>

<P>&#91;Pleskoff97b&#93; O. Pleskoff, N. Sol, B. Labrosse, M. Alizon,
Human immunodeficiency virus strains differ in their ability to
infect CD4+ cells expressing the rat homolog of CXCR-4 (fusin), <I>J
Virol</I>,<B>71</B>:3259-62 (1997).</P>

<P>&#91;Rana97&#93; S. Rana, G. Besson, D. G. Cook, J. Rucker, R. J.
Smyth, Y. Yi, J. D. Turner, H. H. Guo, J. G. Du, S. C. Peiper, E.
Lavi, M. Samson, F. Libert, C. Liesnard, G. Vassart, R. W. Doms, M.
Parmentier, R. G. Collman, Role of CCR5 in infection of primary
macrophages and lymphocytes by macrophage-tropic strains of human
immunodeficiency virus: resistance to patient-derived and prototype
isolates resulting from the delta ccr5 mutation, <I>J
Virol</I>,<B>71</B>:3219-27 (1997).</P>

<P>&#91;Reeves97&#93; J. D. Reeves, A. McKnight, S. Potempa, G.
Simmons, P. W. Gray, C. A. Power, T. Wells, R. A. Weiss, S. J.
Talbot, CD4-independent infection by HIV-2 (ROD/B): use of the
7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry,
<I>Virology</I>,<B>231</B>:130-4 (1997).</P>

<P>&#91;Roos92&#93; M. T. Roos, J. M. Lange, R. E. de Goede, R. A.
Coutinho, P. T. Schellekens, F. Miedema, M. Tersmette, Viral
phenotype and immune response in primary human immunodeficiency virus
type 1 infection, <I>J Infect Dis</I>,<B>165</B>:427-32 (1992).</P>

<P>&#91;Rucker97&#93; J. Rucker, A. L. Edinger, M. Sharron, M.
Samson, B. Lee, J. F. Berson, Y. Yi, B. Margulies, R. G. Collman, B.
J. Doranz, M. Parmentier, R. W. Doms, Utilization of chemokine
receptors, orphan receptors, and herpesvirus encoded receptors by
diverse human and simian immunodeficiency viruses, <I>J
Virol</I>,<B>71</B>:8999-9007 (1997).</P>

<P>&#91;Samson96&#93; M. Samson, F. Libert, B. J. Doranz, J. Rucker,
C. Liesnard, C. M. Farber, S. Saragosti, C. Lapoumeroulie, J.
Cognaux, C. Forceille, G. Muyldermans, C. Verhofstede, G. Burtonboy,
M. Georges, T. Imai, S. Rana, Y. Yi, R. J. Smyth, R. G. Collman, R.
W. Doms, G. Vassart, M. Parmentier, Resistance to HIV-1 infection in
caucasian individuals bearing mutant alleles of the CCR-5 chemokine
receptor gene (see comments), <I>Nature</I>,<B>382</B>:722-5
(1996).</P>

<P>&#91;Samson98&#93; M. Samson, A. L. Edinger, P. Stordeur, J.
Rucker, V. Verhasselt, M. Sharron, C. Govaerts, C. Mollereau, G.
Vassart, R. W. Doms, M. Parmentier, ChemR23, a putative
chemoattractant receptor, is expressed in monocyte- derived dendritic
cells and macrophages and is a coreceptor for SIV and some primary
HIV-1 strains, <I>Eur J Immunol</I>,<B>28</B>:1689-700 (1998).</P>

<P>&#91;Schols98&#93; D. Schols, E. De Clercq, The simian
immunodeficiency virus mnd(GB-1) strain uses CXCR4, not CCR5, as
coreceptor for entry in human cells, <I>J Gen Virol</I>,<B>79 ( Pt
9)</B>:2203-5 (1998).</P>

<P>&#91;Schuitemaker92&#93; H. Schuitemaker, M. Koot, N. A. Kootstra,
M. W. Dercksen, R. E. de Goede, R. P. van Steenwijk, J. M. Lange, J.
K. Schattenkerk, F. Miedema, M. Tersmette, Biological phenotype of
human immunodeficiency virus type 1 clones at different stages of
infection: progression of disease is associated with a shift from
monocytotropic to T-cell-tropic virus population, <I>J
Virol</I>,<B>66</B>:1354-60 (1992).</P>

<P>&#91;Schulz90&#93; T. F. Schulz, D. Whitby, J. G. Hoad, T. Corrah,
H. Whittle, R. A. Weiss, Biological and molecular variability of
human immunodeficiency virus type 2 isolates from The Gambia, <I>J
Virol</I>,<B>64</B>:5177-82 (1990).</P>

<P>&#91;Simmons96&#93; G. Simmons, D. Wilkinson, J. D. Reeves, M. T.
Dittmar, S. Beddows, J. Weber, G. Carnegie, U. Desselberger, P. W.
Gray, R. A. Weiss, P. R. Clapham, Primary, syncytium-inducing human
immunodeficiency virus type 1 isolates are dual-tropic and most can
use either Lestr or CCR5 as coreceptors for virus entry, <I>J
Virol</I>,<B>70</B>:8355-60 (1996).</P>

<P>&#91;Simmons98&#93; G. Simmons, J. D. Reeves, A. McKnight, N.
Dejucq, S. Hibbitts, C. A. Power, E. Aarons, D. Schols, E. De Clercq,
A. E. Proudfoot, P. R. Clapham, CXCR4 as a functional coreceptor for
human immunodeficiency virus type 1 infection of primary macrophages,
<I>J Virol</I>,<B>72</B>:8453-7 (1998).</P>

<P>&#91;Sol97&#93; N. Sol, F. Ferchal, J. Braun, O. Pleskoff, C.
Treboute, I. Ansart, M. Alizon, Usage of the coreceptors CCR-5,
CCR-3, and CXCR-4 by primary and cell line-adapted human
immunodeficiency virus type 2, <I>J Virol</I>,<B>71</B>:8237-44
(1997).</P>

<P>&#91;Sol98&#93; N. Sol, C. Treboute, E. Gomas, F. Ferchal, B.
Shacklett, M. Alizon, The rhesus macaque CCR3 chemokine receptor is a
cell entry cofactor for HIV-2, but not for HIV-1,
<I>Virology</I>,<B>240</B>:213-20 (1998).</P>

<P>&#91;Tersmette88&#93; M. Tersmette, R. E. de Goede, B. J. Al, I.
N. Winkel, R. A. Gruters, H. T. Cuypers, H. G. Huisman, F. Miedema,
Differential syncytium-inducing capacity of human immunodeficiency
virus isolates: frequent detection of syncytium-inducing isolates in
patients with acquired immunodeficiency syndrome (AIDS) and AIDS-
related complex, <I>J Virol</I>,<B>62</B>:2026-32 (1988).</P>

<P>&#91;Tersmette89&#93; M. Tersmette, J. M. Lange, R. E. de Goede,
F. de Wolf, J. K. Eeftink-Schattenkerk, P. T. Schellekens, R. A.
Coutinho, J. G. Huisman, J. Goudsmit, F. Miedema, Association between
biological properties of human immunodeficiency virus variants and
risk for AIDS and AIDS mortality, <I>Lancet</I>,<B>1</B>:983-5
(1989).</P>

<P>&#91;Theodorou97&#93; I. Theodorou, L. Meyer, M. Magierowska, C.
Katlama, C. Rouzioux, HIV-1 infection in an individual homozygous for
CCR5 delta 32. Seroco Study Group (letter),
<I>Lancet</I>,<B>349</B>:1219-20 (1997).</P>

<P>&#91;Trkola96&#93; A. Trkola, T. Dragic, J. Arthos, J. M. Binley,
W. C. Olson, G. P. Allaway, C. Cheng-Mayer, J. Robinson, P. J.
Maddon, J. P. Moore, CD4-dependent, antibody-sensitive interactions
between HIV-1 and its co- receptor CCR-5 (see comments),
<I>Nature</I>,<B>384</B>:184-7 (1996).</P>

<P>&#91;Trkola98&#93; A. Trkola, W. A. Paxton, S. P. Monard, J. A.
Hoxie, M. A. Siani, D. A. Thompson, L. Wu, C. R. Mackay, R. Horuk, J.
P. Moore, Genetic subtype-independent inhibition of human
immunodeficiency virus type 1 replication by CC and CXC chemokines,
<I>J Virol</I>,<B>72</B>:396-404 (1998).</P>

<P>&#91;Tscherning98&#93; C. Tscherning, A. Alaeus, R. Fredriksson,
A. Bjorndal, H. Deng, D. R. Littman, E. M. Fenyo, J. Albert,
Differences in chemokine coreceptor usage between genetic subtypes of
HIV-1, <I>Virology</I>,<B>241</B>:181-8 (1998).</P>

<P>&#91;Vallejo98&#93; A. Vallejo, A. Heredia, A. Mas, S. F. Lee, J.
S. Epstein, V. Soriano, I. K. Hewlett, Tropism, coreceptor use, and
phylogenetic analysis of both the V3 loop and the protease gene of
three novel HIV-1 group O isolates, <I>J Acquir Immune Defic Syndr
Hum Retrovirol</I>,<B>18</B>:417-25 (1998).</P>

<P>&#91;Wu96&#93; L. Wu, N. P. Gerard, R. Wyatt, H. Choe, C. Parolin,
N. Ruffing, A. Borsetti, A. A. Cardoso, E. Desjardin, W. Newman, C.
Gerard, J. Sodroski, CD4-induced interaction of primary HIV-1 gp120
glycoproteins with the chemokine receptor CCR-5 (see comments),
<I>Nature</I>,<B>384</B>:179-83 (1996).</P>

<P>&#91;Yi98&#93; Y. Yi, J. D. Turner, N. Gaddis, R. G. Collman,
CXCR4 is expressed by primary macrophages and supports
CCR5-independent infection by dual-tropic but not T-tropic isolates
of HIV-1, <I>J Virol</I>,<B>Submitted</B>: (year = "1998"}).</P>

<P>&#91;Zhang96&#93; L. Zhang, Y. Huang, T. He, Y. Cao, D. D. Ho,
HIV-1 subtype and second-receptor use (letter),
<I>Nature</I>,<B>383</B>:768 (1996).</P>

<P>&#91;Zhang97&#93; L. Zhang, C. D. Carruthers, T. He, Y. Huang, Y.
Cao, G. Wang, B. Hahn, D. D. Ho, HIV type 1 subtypes, coreceptor
usage, and CCR5 polymorphism, <I>AIDS Res Hum
Retroviruses</I>,<B>13</B>:1357-66 (1997).</P>

<P>&#91;Zhang98&#93; Y. J. Zhang, T. Dragic, Y. Cao, L. Kostrikis, D.
S. Kwon, D. R. Littman, V. N. KewalRamani, J. P. Moore, Use of
coreceptors other than CCR5 by non-syncytium-inducing adult and
pediatric isolates of human immunodeficiency virus type 1 is rare in
vitro, <I>J Virol</I>,<B>72</B>:9337-44 (1998).</P>

<P>&#91;Zhu93&#93; T. Zhu, H. Mo, N. Wang, D. S. Nam, Y. Cao, R. A.
Koup, D. D. Ho, Genotypic and phenotypic characterization of HIV-1
patients with primary infection, <I>Science</I>,<B>261</B>:1179-81
(1993).</P>
</BODY>
</HTML>
</td></tr>
	    <tr><td><table bgcolor="white" width="100%" align="center" cellpadding="0" cellspacing="0" border="0">
  <tr><td>&nbsp;</td></tr>
  <tr><td colspan=2 align=center>Questions or comments? Contact us at <a href="mailto:seq-info@t10.lanl.gov"><font color="#8f8fbd" face="helvetica">seq-info@t10.lanl.gov</font></a></td></tr>
  <tr><td>&nbsp;</td></tr>
</table>



</td></tr>
	  </table>  
        </td>
      </tr>	
    </table>
  </body>
</html>      

<!-- no autohandlers upstream -->


